These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2463733)

  • 21. Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation.
    Zema MJ; Mirando T
    Angiology; 1983 Jan; 34(1):32-9. PubMed ID: 6186164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.
    Dutcher JS; Strong JM
    Clin Chem; 1977 Jul; 23(7):1318-20. PubMed ID: 872378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.
    Lahita R; Kluger J; Drayer DE; Koffler D; Reidenberg MM
    N Engl J Med; 1979 Dec; 301(25):1382-5. PubMed ID: 91972
    [No Abstract]   [Full Text] [Related]  

  • 24. Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methods.
    Azzazy HM; Chou PP; Poklis A; Shock G; Christenson RH
    Clin Biochem; 1998 Feb; 31(1):55-8. PubMed ID: 9559226
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemoperfusion for treatment of N-acetylprocainamide intoxication.
    Braden GL; Fitzgibbons JP; Germain MJ; Ledewitz HM
    Ann Intern Med; 1986 Jul; 105(1):64-5. PubMed ID: 2424355
    [No Abstract]   [Full Text] [Related]  

  • 26. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR; Dhruv RA
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
    Jaillon P; Winkle RA
    Circulation; 1979 Dec; 60(6):1385-94. PubMed ID: 91451
    [No Abstract]   [Full Text] [Related]  

  • 28. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration.
    Domoto DT; Brown WW; Bruggensmith P
    Ann Intern Med; 1987 Apr; 106(4):550-2. PubMed ID: 2435200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites.
    Coyle JD; MacKichan JJ; Boudoulas H; Lima JJ
    J Pharm Sci; 1987 May; 76(5):402-5. PubMed ID: 2443639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.
    Carr K; Woosley RL; Oates JA
    J Chromatogr; 1976 Dec; 129():363-8. PubMed ID: 1002795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of procainamide and N-acetylprocainamide in patients undergoing continuous ambulatory peritoneal dialysis.
    Raehl CL; Moorthy AV; Beirne GJ; Pitterle ME
    Clin Pharm; 1985; 4(6):669-72. PubMed ID: 2416503
    [No Abstract]   [Full Text] [Related]  

  • 32. High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
    Wesley JF; Lasky FD
    Clin Biochem; 1981 Jun; 14(3):113-8. PubMed ID: 6170476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.
    Lam YW; Watkins CE
    Clin Pharm; 1993 Jan; 12(1):49-52. PubMed ID: 7679064
    [No Abstract]   [Full Text] [Related]  

  • 34. Precaution in use of high-pressure liquid chromatographic simultaneous plasma procainamide and N-acetylprocainamide determination.
    Nation RL; Lee MG; Huang SM; Chiou WL
    J Pharm Sci; 1979 Apr; 68(4):532-4. PubMed ID: 438989
    [No Abstract]   [Full Text] [Related]  

  • 35. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F; Alballa RS; Mehvar R; Lemko CH
    Ther Drug Monit; 1988; 10(1):91-6. PubMed ID: 2453956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theophylline, dyphylline, caffeine, acetaminophen, salicylate, acetylsalicylate, procainamide, and N-acetylprocainamide determined in serum with a single liquid-chromatographic assay.
    Ou CN; Frawley VL
    Clin Chem; 1982 Oct; 28(10):2157-60. PubMed ID: 6181911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.